• USEF Network Reminder, if you missed last weekend's @platinumperf /USEF Talent Search Finals East, all the phases are on demand: 10/8/2015 4:27:26 PM
  • USEF Network .@Noelle_Floyd You are correct, our bad! 10/8/2015 1:43:18 PM
  • USEF Network We will have the @nsbits /USEF Junior Jumping Championship and Pessoa/USEF Medal Final available to watch on-demand early next week 10/7/2015 5:04:58 PM
  • USEF Network @cnnsport chatted with Laura Sumrall about her winning freestyle reining performance to Frozen's 'Let it Go': 10/6/2015 4:10:05 PM
  • USEF Network .@PicChick1 The top 10 results were just live streamed. Top 4 in order: Tori, McKayla, Hunter, TJ. Will post complete results ASAP 10/4/2015 2:42:38 PM
  • USEF Network .@PicChick1 We streamed all the way through the awards. If you missed it we will have it all available on demand early next week. 10/4/2015 2:41:16 PM
  • USEF Network We have posted the 4 rides from the final round of the ride-off on our Facebook page for anyone that missed it: 10/4/2015 2:36:30 PM
  • USEF Network Leading Trainer: Andre Dignelli 10/4/2015 2:32:42 PM
  • USEF Network Grapa Trophy (Best Horse) winner: Skyfall owned by Linda Langmeier 10/4/2015 2:31:23 PM
  • USEF Network Talent Search Finals East 2015 Champion: Tori Colvin riding Avalanche 10/4/2015 2:24:43 PM


Adequan Supply Update

RELEASE: September 17, 2013

Shirley, NY- Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., manufacturers of Adequan® IM, Adequan® IA, and Adequan® Canine provides the following supply update:

We are pleased to announce a shipment of Adequan® (polysulfated glycosaminoglycan) IM was released to the market last week and was received by veterinarians beginning Friday, September 13th . Adequan® product supply remains limited and the initial shipments will not fully satisfy market demand. Luitpold made significant investments in upgrading its manufacturing facilities earlier this year. The time spent making these upgrades impacted our ability to keep up with demand. We are working diligently to release additional product to the market and will provide updates as they become available. Quality and integrity remain our highest priorities.

We encourage Adequan® users to continue to work with their veterinarians to obtain the drug and discuss the most appropriate treatment regimen for your animals.

Luitpold has established a dedicated webpage on where concerned parties can register to receive future communications and updates on this matter. You may also contact our Customer Service Department at 1-800-458-0163.

Adequan® IM and IA are the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses. Adequan® Canine is the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.